Special Opportunities Report
This is a paid advertisement on behalf FendX Technologies Please refer to “Forward-Looking Statements and Legal Disclaimers” at the bottom of our featured report for important information.
INVESTOR ALERT:
Unlock the Secrets
of the Lotus Leaf to Create a Potential High-Impact Market Opportunity
Discover how nature’s ultimate non-stick surface is being used by FendX Technologies Inc. (FDXTF:OTCQB, FNDX:CSE, E8D:FSE) to create products that protect surfaces from contamination that could make our lives safer.
In the following report, you’ll discover why the growing antimicrobial coating industry could be a key opportunity for investors…
- You’ll see how FendX’s patent-pending non-stick film and spray products in development use nanotechnology inspired by the Lotus Leaf to repel viruses and bacteria…
- How its design beat out engineers from over 60 countries and was described as ‘the most innovative invention to have a positive impact on the future’…
- How it could be applied to a variety of different surfaces, offering instant protection to reduce the spread of bacteria and viruses…
- And how you have the opportunity to position yourself at an early stage– before the company’s initial scale-up manufacturing tests put it on the potential path to commercialization (assuming tests are successful).
Special Opportunities Report
Tickers:
FDXTF:OTCQB
FNDX:CSE
E8D:FSE
FendX Technologies (FDXTF:OTCQB, FNDX:CSE, E8D:FSE) is pioneering a potential breakthrough in the antimicrobial surface coating market.
Inspired by the hydrophobic lotus leaf, it has a unique topography that consists of nanoscopic wrinkles that are at least a billion times smaller than we can see with the naked eye.
Only this technology doesn’t just repel water… in the lab, it’s shown to repel bacteria and viruses.
The discovery was originally made by scientists at the famed McMaster University.
It’s been detailed in several academic journals, including the prestigious ACS Nano. And it’s backed by a growing patent-pending portfolio.
It’s also been featured on major news and media outlets such as CNN Health, CBC, and Science Daily:
- CNN Health says, “Researchers have developed a self-cleaning plastic wrap that repels bacteria and could be used to prevent the transfer of antibiotic resistant superbugs, and other forms of dangerous bacteria.” [1]
- CBC says, “Scientists engineer self-cleaning surface that can repel dangerous bacteria”[2]
- And Science Daily reports it’s a “self-cleaning surface that repels even the deadliest superbugs.”[3]
Now, to be clear, this nanotechnology is still in the development phase.
Lab tests at McMaster have been successful. Prototypes have been produced. And FendX’s lead product, REPELWRAP™ film, is now with its manufacturing partner who is doing further work to assess how to scale-up development of the film.
It’s not yet available on the market – there’s still work to be done. But think of the potential if it’s successful…
We’re talking about a nanotechnology that could be deployed all over the world.
It could make life safer for you, your children, the elderly, and millions of others.
And as an investor, it commands your immediate attention.
Why You Need to Pay Attention to FendX
Viruses and bacteria are all around us…
On door handles, grocery carts, store checkout stations, payment machines, bathroom sinks/taps, railings, elevator buttons and more.
They cling, grow and thrive on everyday surfaces like glass, paper, and metal.
And they can survive for days… weeks… even months unless disinfected.
Studies have shown that:
- The influenza virus can survive for up to 17 days on things like banknotes[4]…
- Some bacteria – including deadly E. Coli and MRSA – can survive for months on inanimate surfaces.[5]
- And the COVID-19 causing SARS-CoV-2 virus can survive for 28 days on glass, paper, and steel.[6]
These illnesses are all potentially lethal.
Controlling their spread – as well as the spread of other bacteria and viruses – is a global initiative as current disinfecting and hygiene practices are not proving to be enough to manage it.
That’s why there is a need for additional innovative solutions to help to reduce the spread of potentially lethal bacteria and viruses.
And why scientists at McMaster University in Canada, who invented the nanotechnology inspired by the Lotus Leaf (which is licensed by FendX), believe they may have found an answer.
FendX is using their licensed nanotechnology to develop both film and spray coatings to protect high-touch surfaces that are prone to contamination, especially in healthcare and potentially other high traffic venues like schools and transportation.
Their first product in development, REPELWRAP™ film, has been shown in McMaster’s lab to instantly protect against pathogen transmission by preventing bacteria and viruses from sticking to it surface. In fact, it’s ability to safeguard against the spread of potentially deadly pathogens is nothing short of impressive:
REPELWRAP™ film reduces the amount of infectious viral particles for Covid-19 -like viruses by more than 99%…and reduces the formation of bacterial colonies like MRSA and pneumonia-causing Pseudomonas aeruginosa by more than 85%. .[7,8]
REPELWRAP™ film is currently with FendX’s manufacturing partner who is gearing up to do their first automated small-scale runs on their commercial manufacturing line to create intermediate size film samples for testing.
FendX is also working on a spray-on version of this repel technology.
When
sprayed onto a surface, it forms a protective film coating similar to REPELWRAP™ film with the same repelling properties.
It also has a secondary benefit in that it effectively inactivates residual pathogens on the coated surface.
As well, a potential spray product could be easier to apply to many surfaces and may expand potential market applications.
FendX is collaborating with McMaster to further develop the spray nanotechnology as we speak.
But that’s not all…
FendX is also exploring additional applications of their nanotechnology, including development of enhancements to the current REPELWRAP™ film to create follow-on films including films with both repelling and killing properties.
FendX also plans to assess the nanotechnology to develop a coating for catheters to prevent catheter-related blood clot or bacterial colony formation which are known to cause occlusion in long-term use catheters.
To date, FendX in collaboration with McMaster are in early-stage research to assess these additional applications. But FendX believes they will be important additions to the current projects as they may provide expanded applications of their nanotechnology.
As an investor, you might want to pay close attention to FendX (FDXTF:OTCQB, FNDX:CSE).
FendX’s REPELWRAP™ film offers instant, 24-7 protection without the need for continuous disinfecting.
You see, one of the biggest differences is that other antimicrobial coatings require viruses and bacteria to attach to their surface to be killed. Once attached, it can take time for these pathogens to be neutralized which means they have the potential to be passed on – before they are killed – to unsuspecting individuals when they touch the surface.
This creates a “window of transmission” where contaminated surfaces can be hot spots for spreading potential lethal bacteria and viruses – especially in high-traffic touch point areas.
In contrast, FendX’s REPELWRAP™ film’s nano-scale engineering creates a surface that pathogens can’t attach to.
Since pathogens can’t attach, they can’t replicate and create colonies to be passed on.
This means that if a REPELWRAP™ film-coated surface is touched with a contaminated hand, there is a small chance for this contamination to stick and spread.
1) It significantly reduces the transfer of deadly pathogens like MRSA, E-Coli, COVID-19 related viruses.
2) It works instantly.
3) It offers 24-7 protection.
4) And it has numerous potential opportunities in high-impact markets, including healthcare and other high traffic industries.
Handrails… Doorknobs… Countertops… Medical Equipment…
The Market Potential of Antimicrobial Protective Coatings is Huge
Future Markets Inc. estimates the antimicrobial coatings market size will TRIPLE IN SIZE to $11 billion in 2027, up from $3.7 billion in 2022. [9]
FendX has the potential to enter this antimicrobial coating market (should REPELWRAP™ film successfully achieve developmental scale-up to larger sizes and their spray formulation achieve similar objectives).
A key reason why there is a potentially huge opportunity for antimicrobial coatings in healthcare settings is because about 1-in-31 hospital patients get a healthcare-associated infection (HAI). [10]
That’s a huge number of people being exposed to harmful pathogens in what’s “supposed” to be considered a safe environment.
In fact, HAI’s are one of the top 10 leading causes of death in the world.[11]
- In the U.S. alone, it’s estimated that every five minutes a patient dies from an HAI. [12]
These are staggering statistics. So how does it happen?
According to the National Health Institute, contact transmission – when an infected patient comes in direct contact with another individual or contaminates a surface like a doorknob or handrail – is the one of the major modes of transmission in the health care setting. [13]
The direct medical costs associated with these infections are massive, totaling at least $28.4 billion each year. They also account for an additional $12.4 billion in costs to society from early deaths and lost productivity.[14]
And with new virus strains emerging and increasing antibiotic resistant bacteria, there’s a growing demand for innovative solutions to protect against their spread.
This Opportunity Should Be Added to Your Radar
Listen, FendX’s patent-pending technology has the potential to tap into a big opportunity in helping contribute to the global threat of potentially lethal bacterial and viral transmission.
Do your own research now.
Given the difficulty to control the spread of pathogens…
Our heightened awareness of the potential seriousness of infections caused by pathogens…
And the growing potential threat of healthcare-associated infections…
Investors would be wise to closely evaluate FendX Technologies Inc. (FDXTF:OTCQB, FNDX:CSE) as potential future key player in the race to reduce the spread of bacteria and viruses.
Talk to your broker today.
6 Reasons to Consider FendX Technologies Inc. (FDXTF:OTCQB, FNDX:CSE, E8D:FSE):
1) Nanotechnology with Repelling Properties:
FendX’s nanotechnology, inspired by the water-resistant lotus leaves, consists of nanoscopic wrinkles that are a billion-times smaller than what can be seen with the human eye.
These wrinkles create a unique topography that bacteria, viruses – almost anything – can’t stick to. It works instantly and offers 24-7 protection, addressing the growing need for new products to contribute to continuous protection of surfaces prone to contamination to reduce the spread of bacteria and viruses.
Global infections continue to be difficult to control despite efforts to contain their spread. This is increasing the demand for innovative and effective infection control measures.
FendX has the potential to be adopted across various high-traffic public settings such as healthcare facilities, public transportation, schools, and offices. The sheer size and diversity of the target market has the potential to present a large future growth opportunity.
3) New Spray Product in Development:
FendX is working with McMaster University to develop a spray-on version of REPELWRAP™ film using its unique nanotechnology which may prove to be easier to apply to many surfaces and may expand potential market applications.
4) Timely and Relevant:
In an era where public health and safety concerns are at an all-time high, FendX may address the needs and worries of consumers and businesses alike, potentially making it an attractive and relevant opportunity.
5) Different From Other Antimicrobial Coating Films:
FendX’s pathogen-repelling technology is different than other films on the market today.
Other films require viruses and bacteria to attach to their surface to be killed, creating a potential “window of transmission” where bacteria or viruses on the film can still be spread.
FendX uses nanoscale engineering to create surfaces that pathogens can’t attach to. Since pathogens can’t attach, they’re hard to pass on.
6) Future, Untapped Industries May Add Potential:
FendX’s nanotechnology has the potential to be applied to other types of surfaces and materials – such as catheters which could significantly help reduce blockages caused by bacterial colony and/or blood clot formation in long-use catheters.
Underserved markets like this offer potential future upside if the company can successfully adapt their nanotechnology.
Put FendX Technologies (FDXTF:OTCQB, FNDX:CSE) on Your Radar Today!
If you still have questions, contact our Investor Relations Team
You can also download a free investor information package below:
[1] https://www.cnn.com/2019/12/13/health/superbug-repelling-surface-intl-scli-scn/index.html
[2] https://www.cbc.ca/radio/quirks/feb-15-agriculture-moving-north-arrokoth-s-secrets-the-microbiome-for-flight-and-more-1.5463847/canadian-scientists-engineer-self-cleaning-surface-that-can-repel-dangerous-bacteria-1.5463857
[3] https://www.sciencedaily.com/releases/2019/12/191213123554.htm
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394922
[5] https://www.bbc.com/future/article/20200529-the-surfaces-that-kill-bacteria-and-viruses
[6] https://www.cnbc.com/2020/10/12/virus-that-causes-covid-19-can-survive-for-28-days-on-surfaces-research-says.html
[7] https://fendxtech.com/repelwrap/
[8] https://cosmosmagazine.com/technology/materials/repelwrap-repels-viruses/
[9] Future Markets Inc., January 2023
[10] https://www.cdc.gov/policy/polaris/healthtopics/hai/index.html
[11] https://www.who.int/news/item/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control
[12] https://askwonder.com/research/total-number-high-schools-also-known-secondary-schools-universities-known-j4lribx4j
[13] https://www.ncbi.nlm.nih.gov/books/NBK2683/
[14] https://www.cdc.gov/policy/polaris/healthtopics/hai/index.html
IMPORTANT NOTICE AND DISCLAIMER
This article is a paid advertisement. Think Ink Marketing and its owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by profiled companies or third parties to organize marketing campaigns, which include the creation and dissemination of these types of communications. In this case, in an effort to enhance public awareness of FendX Technologies Inc. (“FNDX”) and its securities. FNDX has provided ARU Global Inc. with a budget of approximately $500,000.00 USD. ARU Global Inc. has provided the Publisher with a budget of approximately $10,000.00 USD to cover the costs associated with creating and distribution of this communication. The Publisher may retain any excess sums after expenses as its compensation. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by Native Ads (Market Jar Media)) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP.
The Publisher does not own any shares of any profiled company FNDX and has no information concerning share ownership by others of in the profiled company FNDX. The Publisher cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.
FORWARD LOOKING STATEMENTS.
This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The Publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results of operations. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to FNDX industry; (b) market opportunity; (c) FNDX business plans and strategies; (d) services that FNDX intends to offer; (e) FNDX milestone projections and targets; (f) FNDX expectations regarding receipt of approval for regulatory applications; (g) FNDX intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) FNDX expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute FNDX business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) FNDX ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) FNDX ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) FNDX ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of FNDX to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) FNDX operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact FNDX business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing FNDX business operations (e) FNDX may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.
INDEMNIFICATION/RELEASE OF LIABILITY.
By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
INTELLECTUAL PROPERTY.
Think Ink Marketing is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.
IMPORTANT NOTICE AND DISCLAIMER
This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The Website Host has not been compensated by any of the profiled companies. The Website Host’s compensation for articles appearing on this website is as follows:
- The Website Host has been paid approximately $500 per week while the advertisement campaign is active by Think Ink Marketing as compensation to host the article profiling FendX Technologies Inc. (“FNDX”).
SHARE OWNERSHIP
The Website Host does not own any shares of any profiled compannies and has no information concerning share ownership by others of any profiled companies. The Website Host cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.
NO SECURITIES OFFERED
The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of FNDX or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about FNDX Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in FNDX’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
INDEMNIFICATION/RELEASE OF LIABILITY
By reading articles on this website, you acknowledge that you have read and understood this disclaimer, and further that to the greatest extent permitted under law, you release the Website Host, its affiliates, assigns and successors from any and all liability, damages, and injury from articles appearing on this website. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
LINKS TO THIRD PARTY WEBSITES
This website enables users to link to external websites not under the control of The Website Host. The Website Host has no control over the nature, content, and availability of those sites. The inclusion of any links is not intended as, and should not be construed as, a recommendation or endorsement of the content or views expressed on such external websites. The Website Host expressly disclaims any representation concerning the quality, safety, suitability, or reliability of any external websites and the content and materials contained in them. It is important for users to take necessary precautions, especially to ensure appropriate safety.
INTELLECTUAL PROPERTY
The Market Tactic is the Website Host’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Website Host is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Website Host to any rights in any third-party trademarks.
FORWARD LOOKING INFORMATION
This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect expectations regarding FNDX’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to FNDX’s industry; (b) market opportunity; (c) FNDX’s business plans and strategies; (d) services that FNDX intends to offer; (e) FNDX’s milestone projections and targets; (f) FNDX’s expectations regarding receipt of approval for regulatory applications; (g) FNDX’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) FNDX’s expectations regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute FNDX’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) FNDX’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) FNDX’s ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) FNDX’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of FNDX to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) FNDX’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact FNDX’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing FNDX’s business operations (e) FNDX may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.
HISTORICAL INFORMATION
Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of FNDX or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of FNDX or such entities and are not necessarily indicative of future performance of FNDX or such entities.
PAID ADVERTISEMENT.
This article is a paid advertisement. ARU Global Inc. and its owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by profiled companies or third parties to organize marketing campaigns, which include the creation and dissemination of these types of communications. In this case, in an effort to enhance public awareness of FendX Technologies Inc. (“FNDX”) and its securities, FNDX has provided the Publisher with a budget of approximately $500,000.00 USD to cover the costs associated with creating and distribution of this communication. The Publisher may retain any excess sums after expenses as its compensation. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by FNDX) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP. The owner of ARU Global Inc. may be buying and selling shares of this issuer for its own profit. The Publisher has no information concerning share ownership by others in the profiled company FNDX. The Publisher cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.
FendX Technologies Inc General Disclaimer
This article contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating market, overall market growth rates and the Company’s growth rates and growth strategies; that microbe repellent technology is a promising, high-growth industry; the use of available funds; the performance of the Company’s business and operations; the Company’s expectations regarding revenues, expenses and anticipated cash needs; the intention to grow the Company’s business and operations; the expected timing and completion of the Company’s near-term objectives; laws and regulations and any amendments thereto applicable to the Company; the Company’s competitive advantages and business strategies; the Company’s future product offerings, including potential new applications (i.e. catheters) and new formulations (i.e. spray); the Company’s research and development initiatives and expected results thereof; the Company’s growing patent portfolio; the Company entering into distribution, manufacturing and other business relationships, in Canada, the United States, and globally; the potential of the Company’s technology to protect against the spread of pathogens on surfaces through repelling bacteria and viruses that come in contact with its surface; that the Company’s technology will bring significant value in controlling the spread of surface borne infectious diseases; trends regarding healthcare-acquired infections; proprietary REPELWRAP™ film could be used on high-touch surfaces such as bed rails, doorknobs, and medical devices to help prevent pathogen transmission; the Company’s nanotechnology has the potential to be applied to other types of surfaces and materials –such as catheters which could significantly help reduce blockages caused by bacterial colony and/or blood clot formation in long-use catheters and that underserved markets like this offer potentially future upside, if the Company can successfully adapt their technology; the Company’s intention to initially target REPELWRAP™ film towards healthcare settings and high traffic public touchpoints; that as the Company continues its product development, we may see it used to protect surfaces in other high traffic places like the transportation, education, sports and entertainment sectors; the growing global commitment to reduce the spread of pathogens; the development of the Company’s spray nanotechnology, which could be easier to apply to many surfaces and expand potential market applications; the Company’s organic growth strategy and expansion strategy; line extensions for REPELWRAP™ film; further development of core technology into additional applications (i.e. catheters); expansion into vertical markets; licensing of additional nanotechnology formulations and/or complementary products that reduce pathogen spread; potential licensing, M&A and partnerships within the infectious disease space; and that REPELWRAP™ film will provide additional protection to current disinfecting practices to control the spread of pathogens.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history, no revenues and uncertainty around additional financing; negative cash flow history; no production history and lack of revenues from sales; no history of manufacturing or distribution; highly competitive industry; satisfying the terms of the License Agreement, Spray License Agreement and Collaborative Research Agreement between the Company and McMaster University and maintaining licenses in good standing; inability of McMaster University to satisfy the terms under the License Agreement, Spray License Agreement and Collaborative Research Agreement; completion of scale-up and development of a commercial product; research and development activities; reliance on grant funding; limited number of products; dependence on collaborative partners, licensors and others; changes and restrictions due to legal and regulatory requirements; dependence on each product’s acceptance in the market; possibility of smaller market opportunities than anticipated; increasing regulatory and compliance costs for public companies; global economic instability; product liability claims and lawsuits; system failures; reliance on management and loss of key employees or inability to hire key personnel; limited experience of senior management in managing a public company; fraudulent or illegal activity by employees, contractors and consultants; inability to effect service of process on some of the Company’s directors and officers; management’s efforts and abilities; potential conflicts of interest; inability to protect intellectual property rights; inability to secure patents or grow its patent portfolio; infringement on proprietary rights of third parties; risks related to forward-looking information; volatility of the market price of the Company’s common shares; potential dilution of the common shares; lack of an active, liquid and orderly trading market for the common shares; failure of securities or industry analysts to publish research or publish inaccurate or unfavorable research about the Company; inability or unwillingness to pay dividends; exchange rate fluctuations between the Canadian dollar and the U.S. dollar; effect of COVID-19 public health crisis or another global health pandemic; use of available funds; effect of general economic and political conditions; internal controls; and other risk factors set forth in the Company’s final prospectus dated January 31, 2023 under the heading “Risk Factors” and other filings, publicly available through the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedarplus.ca. The reader is urged to refer to the Company’s prospectus and other filings, publicly available through SEDAR at www.sedarplus.ca for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any Forward-looking statements contained in this presentation are expressly qualified in their entirety by this cautionary statement.
While the information contained in this presentation is believed to be accurate, the Company expressly disclaims any and all liability for any losses, claims or damages of whatsoever kind based upon the information contained in, or omissions from, this presentation or any oral communication transmitted in connection therewith. In addition, none of the statements contained in this presentation are intended to be, nor shall be deemed to be, representations or warranties of the Company. Where the information is from third-party sources, the information is from sources believed to be reliable, but the Company has not independently verified any of such information contained herein.
This presentation is not, and under no circumstances is to be construed as, a prospectus, an offering memorandum, an advertisement or a public offering of securities. Under no circumstances should the information contained herein be considered an offer to sell or a solicitation of an offer to buy any securities.
FDXTF : OTCQB
FNDX : CSE
E8D : FSE
Download a free investor information package
Simply fill out the form below:
FEATURED IN:
VIDEO:
VIDEO:
RELATED NEWS:
July 20, 2023
June 21, 2023
May 25, 2023
May 17, 2023
Social Connect
